Yellow fever vaccination coverage heterogeneities in Luanda province, Angola
In either event, a substantial portion of the truly susceptible population is likely to remain at risk owing to overvaccination in some districts and undervaccination in others.1 In view of the current global yellow fever vaccine shortage, undervaccinated districts in Luanda province are unlikely to...
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2016-09, Vol.16 (9), p.993-995 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 995 |
|---|---|
| container_issue | 9 |
| container_start_page | 993 |
| container_title | The Lancet infectious diseases |
| container_volume | 16 |
| creator | Majumder, Maimuna S Nguyen, Colleen M Mekaru, Sumiko R Brownstein, John S |
| description | In either event, a substantial portion of the truly susceptible population is likely to remain at risk owing to overvaccination in some districts and undervaccination in others.1 In view of the current global yellow fever vaccine shortage, undervaccinated districts in Luanda province are unlikely to achieve 100% vaccination.8 These districts might continue to experience sustained transmission, thus increasing the likelihood of exportation events to other countries. [...]in low-supply settings, our findings suggest that smaller-scale (eg, district-level) coverage heterogeneities--as opposed to larger scale (eg, province-level) vaccination rates--should be carefully considered when developing and monitoring vaccine allocation strategies. |
| doi_str_mv | 10.1016/S1473-3099(16)30260-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1825217932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309916302602</els_id><sourcerecordid>4161799091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-13c7679c90c1a7839925428abf88bc3065abafa01858fa3c040a7507f7f9b6a83</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhS0EoqXwE0CR2BSJFL8fG6qqagFpJBbAgpXleG4Gl4xd7GSq_nucSQGpG7qyffX53HvuQeglwScEE_nuC-GKtQwbc0zkG4apxC19hA5rmbecC_V4f1-QA_SslCuMiSKYP0UHVEnNGaOHaPUdhiHdND3sIDc7532IbgwpNj7VittA8wNGyGkDEcIYoDQhNqvJxbVrrnPahejhbXMWN2lwz9GT3g0FXtydR-jb5cXX84_t6vOHT-dnq9ZzTcaWMK-kMt5gT5zSzBgqONWu67XuPMNSuM71DhMtdO-Yxxw7JbDqVW866TQ7QseLbh3g1wRltNtQfDXiIqSpWKKpoEQZRh-AEiGNYsJU9PU99CpNOVYjM8U5EczwSomF8jmVkqG31zlsXb61BNs5GbtPxs5rt_W1T8bOg7y6U5-6Laz__voTRQVOFwDq5nYBsi0-QN3uOmTwo12n8N8W7-8p-CHE4N3wE26h_HNjC7V4EZk1iNwrUPYbrzSwWA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1814415394</pqid></control><display><type>article</type><title>Yellow fever vaccination coverage heterogeneities in Luanda province, Angola</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Majumder, Maimuna S ; Nguyen, Colleen M ; Mekaru, Sumiko R ; Brownstein, John S</creator><creatorcontrib>Majumder, Maimuna S ; Nguyen, Colleen M ; Mekaru, Sumiko R ; Brownstein, John S</creatorcontrib><description>In either event, a substantial portion of the truly susceptible population is likely to remain at risk owing to overvaccination in some districts and undervaccination in others.1 In view of the current global yellow fever vaccine shortage, undervaccinated districts in Luanda province are unlikely to achieve 100% vaccination.8 These districts might continue to experience sustained transmission, thus increasing the likelihood of exportation events to other countries. [...]in low-supply settings, our findings suggest that smaller-scale (eg, district-level) coverage heterogeneities--as opposed to larger scale (eg, province-level) vaccination rates--should be carefully considered when developing and monitoring vaccine allocation strategies.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(16)30260-2</identifier><identifier>PMID: 27684332</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Angola - epidemiology ; Disease control ; Disease Outbreaks ; Epidemics ; Fever ; Humans ; Immunization ; Infectious Disease ; Infectious diseases ; Vaccination Coverage ; Vaccines ; Vector-borne diseases ; Yellow Fever - epidemiology ; Yellow Fever - prevention & control ; Yellow Fever Vaccine - therapeutic use</subject><ispartof>The Lancet infectious diseases, 2016-09, Vol.16 (9), p.993-995</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Sep 01, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-13c7679c90c1a7839925428abf88bc3065abafa01858fa3c040a7507f7f9b6a83</citedby><cites>FETCH-LOGICAL-c481t-13c7679c90c1a7839925428abf88bc3065abafa01858fa3c040a7507f7f9b6a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1814415394?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27684332$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Majumder, Maimuna S</creatorcontrib><creatorcontrib>Nguyen, Colleen M</creatorcontrib><creatorcontrib>Mekaru, Sumiko R</creatorcontrib><creatorcontrib>Brownstein, John S</creatorcontrib><title>Yellow fever vaccination coverage heterogeneities in Luanda province, Angola</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>In either event, a substantial portion of the truly susceptible population is likely to remain at risk owing to overvaccination in some districts and undervaccination in others.1 In view of the current global yellow fever vaccine shortage, undervaccinated districts in Luanda province are unlikely to achieve 100% vaccination.8 These districts might continue to experience sustained transmission, thus increasing the likelihood of exportation events to other countries. [...]in low-supply settings, our findings suggest that smaller-scale (eg, district-level) coverage heterogeneities--as opposed to larger scale (eg, province-level) vaccination rates--should be carefully considered when developing and monitoring vaccine allocation strategies.</description><subject>Angola - epidemiology</subject><subject>Disease control</subject><subject>Disease Outbreaks</subject><subject>Epidemics</subject><subject>Fever</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Vaccination Coverage</subject><subject>Vaccines</subject><subject>Vector-borne diseases</subject><subject>Yellow Fever - epidemiology</subject><subject>Yellow Fever - prevention & control</subject><subject>Yellow Fever Vaccine - therapeutic use</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNkUtv1DAUhS0EoqXwE0CR2BSJFL8fG6qqagFpJBbAgpXleG4Gl4xd7GSq_nucSQGpG7qyffX53HvuQeglwScEE_nuC-GKtQwbc0zkG4apxC19hA5rmbecC_V4f1-QA_SslCuMiSKYP0UHVEnNGaOHaPUdhiHdND3sIDc7532IbgwpNj7VittA8wNGyGkDEcIYoDQhNqvJxbVrrnPahejhbXMWN2lwz9GT3g0FXtydR-jb5cXX84_t6vOHT-dnq9ZzTcaWMK-kMt5gT5zSzBgqONWu67XuPMNSuM71DhMtdO-Yxxw7JbDqVW866TQ7QseLbh3g1wRltNtQfDXiIqSpWKKpoEQZRh-AEiGNYsJU9PU99CpNOVYjM8U5EczwSomF8jmVkqG31zlsXb61BNs5GbtPxs5rt_W1T8bOg7y6U5-6Laz__voTRQVOFwDq5nYBsi0-QN3uOmTwo12n8N8W7-8p-CHE4N3wE26h_HNjC7V4EZk1iNwrUPYbrzSwWA</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Majumder, Maimuna S</creator><creator>Nguyen, Colleen M</creator><creator>Mekaru, Sumiko R</creator><creator>Brownstein, John S</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Yellow fever vaccination coverage heterogeneities in Luanda province, Angola</title><author>Majumder, Maimuna S ; Nguyen, Colleen M ; Mekaru, Sumiko R ; Brownstein, John S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-13c7679c90c1a7839925428abf88bc3065abafa01858fa3c040a7507f7f9b6a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Angola - epidemiology</topic><topic>Disease control</topic><topic>Disease Outbreaks</topic><topic>Epidemics</topic><topic>Fever</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Vaccination Coverage</topic><topic>Vaccines</topic><topic>Vector-borne diseases</topic><topic>Yellow Fever - epidemiology</topic><topic>Yellow Fever - prevention & control</topic><topic>Yellow Fever Vaccine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Majumder, Maimuna S</creatorcontrib><creatorcontrib>Nguyen, Colleen M</creatorcontrib><creatorcontrib>Mekaru, Sumiko R</creatorcontrib><creatorcontrib>Brownstein, John S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Majumder, Maimuna S</au><au>Nguyen, Colleen M</au><au>Mekaru, Sumiko R</au><au>Brownstein, John S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Yellow fever vaccination coverage heterogeneities in Luanda province, Angola</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>16</volume><issue>9</issue><spage>993</spage><epage>995</epage><pages>993-995</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>In either event, a substantial portion of the truly susceptible population is likely to remain at risk owing to overvaccination in some districts and undervaccination in others.1 In view of the current global yellow fever vaccine shortage, undervaccinated districts in Luanda province are unlikely to achieve 100% vaccination.8 These districts might continue to experience sustained transmission, thus increasing the likelihood of exportation events to other countries. [...]in low-supply settings, our findings suggest that smaller-scale (eg, district-level) coverage heterogeneities--as opposed to larger scale (eg, province-level) vaccination rates--should be carefully considered when developing and monitoring vaccine allocation strategies.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>27684332</pmid><doi>10.1016/S1473-3099(16)30260-2</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2016-09, Vol.16 (9), p.993-995 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1825217932 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
| subjects | Angola - epidemiology Disease control Disease Outbreaks Epidemics Fever Humans Immunization Infectious Disease Infectious diseases Vaccination Coverage Vaccines Vector-borne diseases Yellow Fever - epidemiology Yellow Fever - prevention & control Yellow Fever Vaccine - therapeutic use |
| title | Yellow fever vaccination coverage heterogeneities in Luanda province, Angola |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A14%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Yellow%20fever%20vaccination%20coverage%20heterogeneities%20in%20Luanda%20province,%20Angola&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Majumder,%20Maimuna%20S&rft.date=2016-09-01&rft.volume=16&rft.issue=9&rft.spage=993&rft.epage=995&rft.pages=993-995&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(16)30260-2&rft_dat=%3Cproquest_cross%3E4161799091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1814415394&rft_id=info:pmid/27684332&rft_els_id=S1473309916302602&rfr_iscdi=true |